Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
GSK706769 & KALETRA · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Part 1 | OTHER | GSK706769 new vs. current formulation; GSK706769 alone vs. GSK706769 plus Kaletra |
| Part 2 | OTHER | GSK706769 alone for 10 days; GSK706769 + Kaletra for 14 days |
| Name | Type | Description |
|---|---|---|
| GSK706769 & KALETRA | DRUG | GSK706769 alone and GSK706769 + Kaletra |
Inclusion Criteria: * Healthy as determined by a responsible physician, based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring. A subject with a clinical abnormality or laboratory parameters outside the reference range for the populati...
GSK706769 is an investigational small molecule being studied for the treatment of Human Immunodeficiency Virus (HIV) infection. It is in Phase 1 clinical development and has been evaluated in a drug-drug interaction study in combination with KALETRA. The drug is not yet approved and remains in clinical trials.
GSK706769 is being developed by GSK plc, a global biopharmaceutical company listed on the London Stock Exchange under the ticker GSK. The company is conducting clinical research on this investigational small molecule for the treatment of HIV infection.
GSK706769 is in Phase 1 clinical development. It has completed one Phase 1 trial, a drug-drug interaction study with KALETRA, which enrolled 17 participants. The drug is investigational and has not received regulatory approval.
GSK706769 has been studied in one completed clinical trial, NCT00723775, titled "GSK706769/KALETRA Drug-drug Interaction Study." This Phase 1 trial enrolled 17 participants in the United States and evaluated the drug in healthy volunteers.
No, GSK706769 is not the same as KALETRA. GSK706769 is an investigational small molecule being developed by GSK plc, while KALETRA is a separate drug used in the clinical trial as a combination partner. The study NCT00723775 was designed to assess the drug-drug interaction between the two.